Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Prospective, Multicenter Study to Assess the Continuation Rates and User Acceptability of Bleeding Profile in First-time Users of Low-dose LNG-IUS

NCT04785950 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04785950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04785950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Prospective, Multicenter Study to Assess the Continuation Rates and User Acceptability of Bleeding Profile in First-time Users of Low-dose LNG-IUS
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
February 21, 2021
Completion date
May 4, 2023
Enrollment
316 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hormonal intrauterine contraception